Abstract
In recent years, nanomedicines have shown tremendous progress in their targeted delivery systems and effective anticancer functions. The targeting, solubility, chemical stability, and degradability of nanocarriers make them widely used. The tumor microenvironment is different from that of normal cells. According to the response characteristics of pH, reducibility, hypoxia, reactive oxygen species, and enzymes, a series of tumor microenvironment stimulation–responsive nanocarrier delivery platforms were constructed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aberoumandi S, Mohammadhosseini M, Abasi E, Saghati S, Nikzamir N, Akbarzadeh A, Panahi Y, Davaran S (2017) An update on applications of nanostructured drug delivery systems in cancer therapy: a review. Artif Cells Nanomed Biotechnol 45(6):1–11. https://doi.org/10.1080/21691401.2016.1228658
An N, Lin HM, Yang CY, Zhang T, Tong RH, Chen YH, Qu FY (2016) Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery. Mater Sci Eng C Mater Biol Appl 69:292–300. https://doi.org/10.1016/j.msec.2016.06.086
Baskar R, Lee KA, Yeo R, Yeoh KW (2012) Cancer and radiation therapy: current advances and future directions. Int J Med Sci 9(3):193–199. https://doi.org/10.7150/ijms.3635
Behroozi F, Abdkhodaie MJ, Abandansari HS, Satarian L, Molazem M, Al-Jamal KT, Baharvand H (2018) Engineering folate-targeting diselenide-containing triblock copolymer as a redox-responsive shell-sheddable micelle for antitumor therapy in vivo. Acta Biomater 76:239–256. https://doi.org/10.1016/j.actbio.2018.05.031
Boisselier E, Astruc D (2009) Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 38(6):1759–1782. https://doi.org/10.1039/b806051g
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Burda C, Chen XB, Narayanan R, El-Sayed MA (2005) Chemistry and properties of nanocrystals of different shapes. Chem Rev 105(4):1025–1102. https://doi.org/10.1021/cr030063a
Cai J, Fu JR, Li RR, Zhang F, Ling GX, Zhang P (2019) A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles. Carbohydr Polym 208:356–364. https://doi.org/10.1016/j.carbpol.2018.12.074
Chang S, Wang YF, Zhang TY, Pu XH, Zong LL, Zhu HY, Zhao LL, Feng B (2019) Redox-responsive disulfide bond-bridged mPEG-PBLA prodrug micelles for enhanced paclitaxel biosafety and antitumor efficacy. Front Oncol 9. https://doi.org/10.3389/fonc.2019.00823
Chen Y, Ai KL, Liu JH, Sun GY, Yin Q, Lu LH (2015) Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging. Biomaterials 60:111–120. https://doi.org/10.1016/j.biomaterials.2015.05.003
Chen Q, Liu GX, Liu S, Su HY, Wang Y, Li JY, Luo C (2018) Remodeling the tumor microenvironment with emerging nanotherapeutics. Trends Pharmacol Sci 39(1):59–74. https://doi.org/10.1016/j.tips.2017.10.009
Cheng YJ, Luo GF, Zhu JY, Xu XD, Zeng X, Cheng DB, Li YM, Wu Y, Zhang XZ, Zhuo RX, He F (2015) Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. ACS Appl Mater Interfaces 7(17):9078–9087. https://doi.org/10.1021/acsami.5b00752
Chiang YT, Yen YW, Lo CL (2015) Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer. Biomaterials 61:150–161. https://doi.org/10.1016/j.biomaterials.2015.05.007
Cotrin SS, Puzer L, Judice WAD, Juliano L, Carmona AK, Juliano MA (2004) Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B. Anal Biochem 335(2):244–252. https://doi.org/10.1016/j.ab.2004.09.012
de la Torre C, Mondragon L, Coll C, Sancenon F, Marcos MD, Martinez-Manez R, Amoros P, Perez-Paya E, Orzaez M (2014) Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles. Chem Eur J 20(47):15309–15314. https://doi.org/10.1002/chem.201404382
Deirram N, Zhang CH, Kermaniyan SS, Johnston APR, Such GK (2019) pH-responsive polymer nanoparticles for drug delivery. Macromol Rapid Commun 40(10):1800917. https://doi.org/10.1002/marc.201800917
Deslongchamps P, Dory YL, Li SG (2000) The relative rate of hydrolysis of a series of acyclic and six-membered cyclic acetals, ketals, orthoesters, and orthocarbonates. Tetrahedron 56(22):3533–3537. https://doi.org/10.1016/s0040-4020(00)00270-2
Doane TL, Burda C (2012) The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 41(7):2885–2911. https://doi.org/10.1039/c2cs15260f
Dong CY, Zhou Q, Xiang JJ, Liu FS, Zhou ZX, Shen YQ (2020) Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy. J Control Release 321:529–539. https://doi.org/10.1016/j.jconrel.2020.02.038
Fang Y, Xue JX, Gao S, Lu AQ, Yang DJ, Jiang H, He Y, Shi K (2017) Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery. Drug Deliv 24(2):22–32. https://doi.org/10.1080/10717544.2017.1388451
Gao WW, Hu CMJ, Fang RH, Zhang LF (2013) Liposome-like nanostructures for drug delivery. J Mater Chem B 1(48):6569–6585. https://doi.org/10.1039/c3tb21238f
Gilkes DM, Semenza GL, Wirtz D (2014) Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer 14(6):430–439. https://doi.org/10.1038/nrc3726
Graf N, Lippard SJ (2012) Redox activation of metal-based prodrugs as a strategy for drug delivery. Adv Drug Deliv Rev 64(11):993–1004. https://doi.org/10.1016/j.addr.2012.01.007
Habibi N, Kamaly N, Memic A, Shafiee H (2016) Self-assembled peptide-based nanostructures: smart nanomaterials toward targeted drug delivery. Nano Today 11(1):41–60. https://doi.org/10.1016/j.nantod.2016.02.004
Hall MD, Failes TW, Yamamoto N, Hambley TW (2007) Bioreductive activation and drug chaperoning in cobalt pharmaceuticals. Dalton Trans 36:3983–3990. https://doi.org/10.1039/b707121c
Hinds G, Thomas VD (2008) Malignancy and cancer treatment-related hair and nail changes. Dermatol Clin 26(1):59−+. https://doi.org/10.1016/j.det.2007.08.003
Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134(5):703–707. https://doi.org/10.1016/j.cell.2008.08.021
Hu JJ, Lei Q, Peng MY, Zheng DW, Chen YX, Zhang XZ (2017) A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem. Biomaterials 128:136–146. https://doi.org/10.1016/j.biomaterials.2017.03.010
Jang EH, Kim GL, Park MG, Shim MK, Kim J-H (2020) Hypoxia-responsive, organic -inorganic hybrid mesoporous silica nanoparticles for triggered drug release. J Drug Deliv Sci Technol 56. https://doi.org/10.1016/j.jddst.2020.101543
Kanamala M, Palmer BD, Ghandehari H, Wilson WR, Wu ZM (2018) PEG-benzaldehyde-hydrazone-lipid based PEG-Sheddable pH-sensitive liposomes: abilities for endosomal escape and Long circulation. Pharm Res 35(8). https://doi.org/10.1007/s11095-018-2429-y
Khatoon S, Han HS, Jeon J, Rao NV, Jeong DW, Ikram M, Yasin T, Yi GR, Park JH (2018) Hypoxia-responsive mesoporous nanoparticles for doxorubicin delivery. Polymers 10(4). https://doi.org/10.3390/polym10040390
Kievit FM, Zhang MQ (2011) Surface engineering of Iron oxide nanoparticies for targeted cancer therapy. Acc Chem Res 44(10):853–862. https://doi.org/10.1021/ar2000277
Kim SW, Oh KT, Youn YS, Lee ES (2014) Hyaluronated nanoparticles with pH- and enzyme-responsive drug release properties. Colloids Surf B Biointerfaces 116:359–364. https://doi.org/10.1016/j.colsurfb.2014.01.017
Kim YS, Kim S, Kang HC, Shim MS (2019) ROS-responsive thioether-based nanocarriers for efficient pro-oxidant cancer therapy. J Ind Eng Chem 75:238–245. https://doi.org/10.1016/j.jiec.2019.03.030
Kuang TR, Liu YR, Gong TT, Peng XF, Hu XL, Yu ZQ (2016) Enzyme-responsive nanoparticles for anticancer drug delivery. Curr Nanosci 12(1):38–46. https://doi.org/10.2174/1573413711666150624170518
Li Y, Lu AL, Long MM, Cui L, Chen ZP, Zhu L (2019) Nitroimidazole derivative incorporated liposomes for hypoxia-triggered drug delivery and enhanced therapeutic efficacy in patient-derived tumor xenografts. Acta Biomater 83:334–348. https://doi.org/10.1016/j.actbio.2018.10.029
Li RR, Peng FF, Cai J, Yang DD, Zhang P (2020) Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects. Asian J Pharm Sci 15(3):311–325. https://doi.org/10.1016/j.ajps.2019.06.003
Liang J, Liu B (2016) ROS-responsive drug delivery systems. Bioeng Transl Med 1(3):239–251. https://doi.org/10.1002/btm2.10014
Liang YQ, Li SX, Wang XL, Zhang Y, Sun YN, Wang YQ, Wang XY, He B, Dai WB, Zhang H, Wang XQ, Zhang Q (2018) A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers. J Control Release 275:129–141. https://doi.org/10.1016/j.jconrel.2018.01.033
Lim EK, Chung BH, Chung SJ (2018) Recent advances in pH-sensitive polymeric nanoparticles for smart drug delivery in cancer therapy. Curr Drug Targets 19(4):300–317. https://doi.org/10.2174/1389450117666160602202339
Louage B, van Steenbergen MJ, Nuhn L, Risseeuw MDP, Karalic I, Winne J, Van Calenbergh S, Hennik WE, De Geest BG (2017) Micellar paclitaxel-initiated RAFT polymer conjugates with acid-sensitive behavior. ACS Macro Lett 6(3):272–276. https://doi.org/10.1021/acsmacrolett.6b00977
Luo WB, Wang YF (2019) Hypoxia mediates tumor malignancy and therapy resistance. Hypoxia and Cancer Metastasis 1136:1–18. https://doi.org/10.1007/978-3-030-12734-3_1
Luo C, Sun BJ, Wang C, Zhang XB, Chen Y, Chen Q, Yu H, Zhao HQ, Sun MC, Li ZB, Zhang HT, Kan QM, Wang YJ, He ZG, Sun J (2019) Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy. J Control Release 302:79–89. https://doi.org/10.1016/j.jconrel.2019.04.001
Lux CD, Joshi-Barr S, Nguyen T, Mahmoud E, Schopf E, Fomina N, Almutairi A (2012) Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. J Am Chem Soc 134(38):15758–15764. https://doi.org/10.1021/ja303372u
Mo R, Gu Z (2016) Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery. Mater Today 19(5):274–283. https://doi.org/10.1016/j.mattod.2015.11.025
Nam J, Won N, Bang J, Jin H, Park J, Jung S, Jung S, Park Y, Kim S (2013) Surface engineering of inorganic nanoparticles for imaging and therapy. Adv Drug Deliv Rev 65(5):622–648. https://doi.org/10.1016/j.addr.2012.08.015
Nicolas J (2016) Drug-initiated synthesis of polymer prodrugs: combining simplicity and efficacy in drug delivery. Chem Mater 28(6):1591–1606. https://doi.org/10.1021/acs.chemmater.5b04281
Ou KY, Xu XJ, Guan SY, Zhang RH, Zhang XY, Kang Y, Wu J (2020) Nanodrug carrier based on poly(ursolic acid) with self-anticancer activity against colorectal cancer. Adv Funct Mater 30(9):1907857. https://doi.org/10.1002/adfm.201907857
Oun R, Moussa YE, Wheate NJ (2018) The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans 47(19):6645–6653. https://doi.org/10.1039/c8dt00838h
Peer D, Karp JM, Hong S, FaroKhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751–760. https://doi.org/10.1038/nnano.2007.387
Peng X, Yang C, Kong X, Xiang Y, Dai W, Quan H (2020a) Multifunctional nanocomposites MGO/FU-MI inhibit the proliferation of tumor cells and enhance the effect of chemoradiotherapy in vivo and in vitro. Clin Transl Oncol 22(10):1875–1884. https://doi.org/10.1007/s12094-020-02331-9
Peng FF, Li RR, Zhang F, Qin L, Ling GX, Zhang P (2020b) Potential drug delivery nanosystems for improving tumor penetration. Eur J Pharm Biopharm 151:220–238. https://doi.org/10.1016/j.ejpb.2020.04.009
Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G, Migliaccio A (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52(2):192–203. https://doi.org/10.1038/s12276-020-0384-2
Plumb JA, Bilsland A, Kakani R, Zhao J, Glasspool RM, Knox RJ, Evans TR, Keith WN (2001) Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. Oncogene 20(53):7797–7803. https://doi.org/10.1038/sj.onc.1204954
Pu XH, Zhao LL, Li J, Song RF, Wang YL, Yu KK, Hou XQ, Qiao P, Zong LL, Chang S (2019) A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin. Acta Biomater 88:357–369. https://doi.org/10.1016/j.actbio.2019.02.039
Rad AT, Chen CW, Aresh W, Xia Y, Lai PS, Nieh MP (2019) Combinational effects of active targeting, shape, and enhanced permeability and retention for cancer theranostic nanocarriers. ACS Appl Mater Interfaces 11(11):10505–10519. https://doi.org/10.1021/acsami.8b21609
Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H (2009) Nanomedicine-challenge and perspectives. Angew Chem Int Ed Engl 48(5):872–897. https://doi.org/10.1002/anie.200802585
Saito G, Swanson JA, Lee KD (2003) Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev 55(2):199–215. https://doi.org/10.1016/s0169-409x(02)00179-5
Sedlacek O, Monnery BD, Mattova J, Kucka J, Panek J, Janouskova O, Hocherl A, Verbraeken B, Vergaelen M, Zadinova M, Hoogenboom R, Hruby M (2017) Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: in vitro and in vivo evaluation and direct comparison to poly N-(2-hydroxypropyl)methacrylamide analogues. Biomaterials 146:1–12. https://doi.org/10.1016/j.biomaterials.2017.09.003
Shi JJ, Kantoff PW, Wooster R, Farokhzad OC (2017) Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17(1):20–37. https://doi.org/10.1038/nrc.2016.108
Shim MK, Park J, Yoon HY, Lee S, Um W, Kim JH, Kang SW, Seo JW, Hyun SW, Park JH, Byun Y, Kwon IC, Kim K (2019) Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy. J Control Release 294:376–389. https://doi.org/10.1016/j.jconrel.2018.11.032
Thambi T, Park JH, Lee DS (2016) Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives. Chem Commun 52(55):8492–8500. https://doi.org/10.1039/c6cc02972h
Torchilin V (2011) Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63(3):131–135. https://doi.org/10.1016/j.addr.2010.03.011
Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579–591. https://doi.org/10.1038/nrd2803
Tubbs JL, Pegg AE, Tainer JA (2007) DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O-6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy. DNA Repair 6(8):1100–1115. https://doi.org/10.1016/j.dnarep.2007.03.011
Wang Y, Hu W, Ding B, Chen D, Cheng L (2020) cRGD mediated redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for efficiently intracellular antitumor drug delivery. Colloids Surfaces B Biointerfaces 194. https://doi.org/10.1016/j.colsurfb.2020.111195
Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter CJH (2013) Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65(1):315–499. https://doi.org/10.1124/pr.112.005660
Xie JJ, Fan ZX, Li Y, Zhang YY, Yu F, Su GH, Xie LY, Hou ZQ (2018) Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy. Int J Nanomedicine 13:1381–1398. https://doi.org/10.2147/ijn.S152312
Xie XD, Zhang XM, Chen J, Tang X, Wang MQ, Zhang L, Guo Z, Shen WR (2019) Fe3O4-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells. Int J Oncol 54(3):905–915. https://doi.org/10.3892/ijo.2018.4637
Xu KH, Wang F, Pan XH, Liu RP, Ma J, Kong FP, Tang B (2013) High selectivity imaging of nitroreductase using a near-infrared fluorescence probe in hypoxic tumor. Chem Commun 49(25):2554–2556. https://doi.org/10.1039/c3cc38980d
Zeng Y, Ma JW, Zhan YH, Xu XY, Zeng Q, Liang JM, Chen XL (2018) Hypoxia-activated prodrugs and redox-responsive nanocarriers. Int J Nanomedicine 13:6551–6574. https://doi.org/10.2147/ijn.S173431
Zhang ZT, Huang-Fu MY, Xu WH, Han M (2019) Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment. Eur J Pharm Biopharm 137:122–130. https://doi.org/10.1016/j.ejpb.2019.02.009
Zheng YH, You XR, Guan SY, Huang J, Wang LY, Zhang JY, Wu J (2019) Poly(Ferulic acid) with an anticancer effect as a drug nanocarrier for enhanced colon cancer therapy. Adv Funct Mater 29(15):1808646. https://doi.org/10.1002/adfm.201808646
Zhu R, Baumann RP, Penketh PG, Shyam K, Sartorelli AC (2013) Hypoxia-selective O-6-alkylguanine-DNA alkyltransferase inhibitors: design, synthesis, and evaluation of 6-(Benzyloxy)-2-(aryldiazenyl)-9H-purines as prodrugs of O-6-benzylguanine. J Med Chem 56(3):1355–1359. https://doi.org/10.1021/jm301804p
Zong LL, Wang YL, Qiao P, Yu KK, Hou XQ, Wang PR, Zhang ZK, Pang XB, Pu XH, Yuan Q (2020) Reduction-sensitive poly(ethylene glycol)-polypeptide conjugate micelles for highly efficient intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin. Nanotechnology 31(16):165102. https://doi.org/10.1088/1361-6528/ab6749
Funding
This study was funded by National Nature Science Foundation of China (81202480, 81302723).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, X., Yang, X., Wu, R. et al. Research progress of response strategies based on tumor microenvironment in drug delivery systems. J Nanopart Res 23, 64 (2021). https://doi.org/10.1007/s11051-020-05136-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-020-05136-7